Pure Global

CK-MB FIA Test - India CDSCO Medical Device Registration

CK-MB FIA Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000062_cbdfd7f1a1e17f8dc58816334f797884_ccaed508d12e4fb3e686f17f84c8aefb. This device is marketed under the brand name hCG. The license holder is Mylab Discovery Solutions Pvt. Ltd. Lonavla, and it is classified as Device Class Class B. The approving authority is Pune Division.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
CK-MB FIA Test
UID: MFG/IVD/2021/000062_cbdfd7f1a1e17f8dc58816334f797884_ccaed508d12e4fb3e686f17f84c8aefb

Brand Name

hCG

Device Class

Class B

Approving Authority

Pune Division

Product Information

CK-MB FIA Test is a fluorescence immunoassay for the quantitative determination of total Creatine Kinase Isoenzyme-MB (hCG) levels in the human specimen using FIA Analyzers. This test is an in vitro diagnostic use and intended for use as an aid in the screening and monitoring of myocardiac infarction (hCG). The test is intended for professional testing. More specific alternative diagnosis methods should be performed to obtain the confirmation of total CK-MB

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing